Ticker brief

ACA

last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
16
authors 14d
12

No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.

Sentiment — last 14 days
daily mean sentiment, 2026-06-21 → 2026-06-28 · now +0.35 (−1 bearish … +1 bullish)
Who spoke12
authorgradetrader scoresignalsmean sent
@ConsensusGurusB+1.103+0.32
@Brad_E_SchulzC·2+0.30
@financespotnewsC-0.872+0.53
@IngJuanPa7B+2.301+0.50
@cnfinancewatchB-1.611+0.50
@OpenOutcrierC·1+0.50
@TWFeditorC+0.571+0.25
@SquawkStreetC-0.551+0.50
@akishoreC+1.671+0.50
@LeifSoreideC-0.831+0.20
@AnthonySandfordC·1+0.10
@ThePupOfWallStC-2.681+0.35
Recent signals16of 16 in 14d — receipts included
date (PT)authorsentwhat they saidsince thenreceipt
2026-06-28@ThePupOfWallSt+0.35Highlights retail and construction names trading strongly near highs/uptrends.·
2026-06-27@financespotnews+0.50CRH agreed to acquire Arcosa for $8.5B cash at $150/share, 25% premium.·
2026-06-25@AnthonySandford+0.10Dark pool feed lists large single-stock prints across tech, healthcare and other sectors.·
2026-06-22@Brad_E_Schulz+0.30Lists stocks up at least 4% on 1.5x average volume or higher.·
2026-06-22@LeifSoreide+0.20STRL had a solid add spot; ACA acquisition may boost engineering sentiment.·
2026-06-22@akishore+0.50CRH paid 32% premium for ACA at $150/share; assets align with infrastructure and clean energy spending.·
2026-06-22@financespotnews+0.55CRH agreed to acquire ACA for $8.5B cash at $150/share.·
2026-06-22@SquawkStreet+0.50CRH CEO discusses the company's plan to acquire ACA for $8.5B.·
2026-06-22@Brad_E_Schulz+0.30Intraday list of stocks up at least 4% on elevated average volume.·
2026-06-22@TWFeditor+0.25Royce fundholders expected to gain from exit of remaining ACA stake.·
2026-06-22@ConsensusGurus+0.00Notes both names traded 2x volume before announcements, implying suspicious activity.·
2026-06-22@OpenOutcrier+0.50CRH to buy Arcosa in $8.5B all-cash deal at $150 per share.·
2026-06-22@cnfinancewatch+0.50News roundup includes announced acquisitions of APGE by ABBV and ACA by CRH with deal values and premium.·
2026-06-22@IngJuanPa7+0.50CRH announced all-cash acquisition of Arcosa for about $8.5B at $150/share, 10.4% premium.·
2026-06-22@ConsensusGurus+0.50Reports CRH buying Arcosa for $150/share and AbbVie buying Apogee for $135.11/share cash.·
2026-06-21@ConsensusGurus+0.45FT reports CRH nears biggest-ever deal to buy Arcosa; author notes timing feels off.·

“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.